Ten Haaf K - Search Results

1

Cost-effectiveness Analysis of Breast Cancer Screening Using Mammography in Singapore: A Modeling Study.

Chootipongchaivat S, Wong XY, Ten Haaf K, Hartman M, Tan KB, van Ravesteyn NT, Wee HL. Chootipongchaivat S, et al. Among authors: ten haaf k. Cancer Epidemiol Biomarkers Prev. 2021 Apr;30(4):653-660. doi: 10.1158/1055-9965.EPI-20-1230. Epub 2021 Feb 2. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 33531436 Free PMC article.

2

Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trials.

Ten Haaf K, van Rosmalen J, de Koning HJ. Ten Haaf K, et al. Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):154-61. doi: 10.1158/1055-9965.EPI-14-0745. Epub 2014 Oct 13. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 25312998 Free PMC article. Clinical Trial.

3

Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?

Ten Haaf K, de Koning HJ. Ten Haaf K, et al. J Thorac Oncol. 2015 Sep;10(9):1285-1291. doi: 10.1097/JTO.0000000000000593. J Thorac Oncol. 2015. PMID: 26287320 Free PMC article.

4

Clarifying Assumptions and Outcomes in Cost-effectiveness Analyses.

ten Haaf K, de Koning HJ. ten Haaf K, et al. JAMA Oncol. 2016 Feb;2(2):277-8. doi: 10.1001/jamaoncol.2015.4457. JAMA Oncol. 2016. PMID: 26869001 Free PMC article. No abstract available.

5

Extrapolation of pre-screening trends: Impact of assumptions on overdiagnosis estimates by mammographic screening.

Ripping TM, Verbeek AL, Ten Haaf K, van Ravesteyn NT, Broeders MJ. Ripping TM, et al. Among authors: ten haaf k. Cancer Epidemiol. 2016 Jun;42:147-53. doi: 10.1016/j.canep.2016.04.015. Epub 2016 May 3. Cancer Epidemiol. 2016. PMID: 27153471 Free article.

6

The impact of overdiagnosis on the selection of efficient lung cancer screening strategies.

Han SS, Ten Haaf K, Hazelton WD, Munshi VN, Jeon J, Erdogan SA, Johanson C, McMahon PM, Meza R, Kong CY, Feuer EJ, de Koning HJ, Plevritis SK. Han SS, et al. Among authors: ten haaf k. Int J Cancer. 2017 Jun 1;140(11):2436-2443. doi: 10.1002/ijc.30602. Int J Cancer. 2017. PMID: 28073150 Free PMC article.

7

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.

Ten Haaf K, Tammemägi MC, Bondy SJ, van der Aalst CM, Gu S, McGregor SE, Nicholas G, de Koning HJ, Paszat LF. Ten Haaf K, et al. PLoS Med. 2017 Feb 7;14(2):e1002225. doi: 10.1371/journal.pmed.1002225. eCollection 2017 Feb. PLoS Med. 2017. PMID: 28170394 Free PMC article.

8

Quantifying Overdiagnosis in Cancer Screening: A Systematic Review to Evaluate the Methodology.

Ripping TM, Ten Haaf K, Verbeek ALM, van Ravesteyn NT, Broeders MJM. Ripping TM, et al. Among authors: ten haaf k. J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx060. J Natl Cancer Inst. 2017. PMID: 29117353 Review.

9

Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling study.

Tomonaga Y, Ten Haaf K, Frauenfelder T, Kohler M, Kouyos RD, Shilaih M, Lorez M, de Koning HJ, Schwenkglenks M, Puhan MA. Tomonaga Y, et al. Among authors: ten haaf k. Lung Cancer. 2018 Jul;121:61-69. doi: 10.1016/j.lungcan.2018.05.008. Epub 2018 May 26. Lung Cancer. 2018. PMID: 29858029

10

Treatment capacity required for full-scale implementation of lung cancer screening in the United States.

Blom EF, Ten Haaf K, Arenberg DA, de Koning HJ. Blom EF, et al. Among authors: ten haaf k. Cancer. 2019 Jun 15;125(12):2039-2048. doi: 10.1002/cncr.32026. Epub 2019 Feb 27. Cancer. 2019. PMID: 30811590 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters